Andrew Leber

931 total citations
41 papers, 647 citations indexed

About

Andrew Leber is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Andrew Leber has authored 41 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 13 papers in Infectious Diseases and 12 papers in Molecular Biology. Recurrent topics in Andrew Leber's work include Immune Cell Function and Interaction (11 papers), Inflammatory Bowel Disease (10 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Andrew Leber is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Inflammatory Bowel Disease (10 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Andrew Leber collaborates with scholars based in United States, Australia and Italy. Andrew Leber's co-authors include Raquel Hontecillas, Victoria Zoccoli-Rodriguez, Nuria Tubau‐Juni, Josep Bassaganya‐Riera, Josep Bassaganya-Riera, Vida Abedi, Raquel Hontecillas, Casandra Philipson, Stefan Hoops and Adria Carbo and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.

In The Last Decade

Andrew Leber

39 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Leber United States 17 252 248 107 89 87 41 647
María Daniella Carretta Chile 19 319 1.3× 314 1.3× 47 0.4× 55 0.6× 61 0.7× 34 847
Pablo Alarcón Chile 19 270 1.1× 384 1.5× 57 0.5× 38 0.4× 53 0.6× 48 973
Mariana Haydee García-Hernández Mexico 17 261 1.0× 252 1.0× 109 1.0× 78 0.9× 41 0.5× 41 834
Gabriel Fung Canada 17 571 2.3× 212 0.9× 205 1.9× 83 0.9× 42 0.5× 22 1.2k
Deepa Machiah United States 12 304 1.2× 208 0.8× 92 0.9× 39 0.4× 126 1.4× 18 765
Katarzyna Kołodziejska Poland 10 376 1.5× 334 1.3× 83 0.8× 73 0.8× 104 1.2× 20 1.0k
Eric M. Walton United States 10 193 0.8× 238 1.0× 177 1.7× 68 0.8× 59 0.7× 11 637
Paul Cheung Canada 17 369 1.5× 173 0.7× 91 0.9× 51 0.6× 109 1.3× 21 871
Ann-Katrin Hopp Switzerland 12 272 1.1× 204 0.8× 35 0.3× 32 0.4× 41 0.5× 20 757

Countries citing papers authored by Andrew Leber

Since Specialization
Citations

This map shows the geographic impact of Andrew Leber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Leber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Leber more than expected).

Fields of papers citing papers by Andrew Leber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Leber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Leber. The network helps show where Andrew Leber may publish in the future.

Co-authorship network of co-authors of Andrew Leber

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Leber. A scholar is included among the top collaborators of Andrew Leber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Leber. Andrew Leber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leber, Andrew, Raquel Hontecillas, Nuria Tubau‐Juni, & Josep Bassaganya‐Riera. (2025). Safety, Tolerability, and Pharmacokinetics of NIM‐1324 an Oral LANCL2 Agonist in a Randomized, Double‐Blind, Placebo‐Controlled Phase I Clinical Trial. Clinical and Translational Science. 18(1). e70129–e70129. 2 indexed citations
2.
Tubau‐Juni, Nuria, et al.. (2023). Modulation of colonic immunometabolic responses during Clostridioides difficile infection ameliorates disease severity and inflammation. Scientific Reports. 13(1). 14708–14708. 5 indexed citations
3.
Leber, Andrew, et al.. (2023). S1076 Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn’s Disease. The American Journal of Gastroenterology. 118(10S). S820–S821. 3 indexed citations
4.
Leber, Andrew, et al.. (2023). Blockade of IL-18 signaling downregulates homing of effector CD4+ T cells to the gut mucosa and provides protection from experimental IBD. The Journal of Immunology. 210(Supplement_1). 143.08–143.08. 1 indexed citations
5.
Baker, Ryan S., Raquel Hontecillas, Nuria Tubau‐Juni, et al.. (2022). Computational modeling of complex bioenergetic mechanisms that modulate CD4+ T cell effector and regulatory functions. npj Systems Biology and Applications. 8(1). 45–45. 5 indexed citations
6.
Tubau‐Juni, Nuria, et al.. (2021). Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are Morphotype and Cell Type Specific. Frontiers in Immunology. 12. 749504–749504. 6 indexed citations
7.
Leber, Andrew, Raquel Hontecillas, Nuria Tubau‐Juni, et al.. (2020). Abscisic acid enriched fig extract promotes insulin sensitivity by decreasing systemic inflammation and activating LANCL2 in skeletal muscle. Scientific Reports. 10(1). 10463–10463. 20 indexed citations
8.
Tubau‐Juni, Nuria, et al.. (2020). NLRX1 is a key regulator of immune signaling during invasive pulmonary aspergillosis. PLoS Pathogens. 16(9). e1008854–e1008854. 19 indexed citations
9.
Atkinson, Fiona, A Zangara, Ester Risco, et al.. (2019). Abscisic Acid Standardized Fig (Ficus carica) Extracts Ameliorate Postprandial Glycemic and Insulinemic Responses in Healthy Adults. Nutrients. 11(8). 1757–1757. 27 indexed citations
10.
Leber, Andrew, Raquel Hontecillas, Nuria Tubau‐Juni, et al.. (2018). NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host–Gut Microbiota Interactions during Inflammatory Bowel Disease. Frontiers in Immunology. 9. 363–363. 53 indexed citations
11.
Kale, Shiv D., Dawoon Chung, Nuria Tubau‐Juni, et al.. (2017). Modulation of Immune Signaling and Metabolism Highlights Host and Fungal Transcriptional Responses in Mouse Models of Invasive Pulmonary Aspergillosis. Scientific Reports. 7(1). 17096–17096. 24 indexed citations
12.
Zocchi, Elena, Raquel Hontecillas, Andrew Leber, et al.. (2017). Abscisic Acid: A Novel Nutraceutical for Glycemic Control. Frontiers in Nutrition. 4. 24–24. 61 indexed citations
13.
Viladomiu, Monica, Josep Bassaganya-Riera, Nuria Tubau‐Juni, et al.. (2017). Cooperation of Gastric Mononuclear Phagocytes with Helicobacter pylori during Colonization. The Journal of Immunology. 198(8). 3195–3204. 15 indexed citations
14.
Leber, Andrew, Raquel Hontecillas, Vida Abedi, et al.. (2017). Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection. Artificial Intelligence in Medicine. 78. 1–13. 21 indexed citations
15.
Leber, Andrew, Vida Abedi, Raquel Hontecillas, et al.. (2016). Bistability analyses of CD4+ T follicular helper and regulatory cells during Helicobacter pylori infection. Journal of Theoretical Biology. 398. 74–84. 18 indexed citations
16.
Leber, Andrew, Raquel Hontecillas, Nuria Tubau‐Juni, & Josep Bassaganya-Riera. (2016). Translating nutritional immunology into drug development for inflammatory bowel disease. Current Opinion in Gastroenterology. 32(6). 443–449. 3 indexed citations
17.
Leber, Andrew, Josep Bassaganya‐Riera, Nuria Tubau‐Juni, et al.. (2016). Modeling the Role of Lanthionine Synthetase C-Like 2 (LANCL2) in the Modulation of Immune Responses to Helicobacter pylori Infection. PLoS ONE. 11(12). e0167440–e0167440. 13 indexed citations
18.
Lu, Pinyi, Raquel Hontecillas, Vida Abedi, et al.. (2015). Modeling-Enabled Characterization of Novel NLRX1 Ligands. PLoS ONE. 10(12). e0145420–e0145420. 24 indexed citations
19.
Leber, Andrew, Monica Viladomiu, Raquel Hontecillas, et al.. (2015). Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection. PLoS ONE. 10(7). e0134849–e0134849. 22 indexed citations
20.
Spiess, Bernhard M., G. Mathis, Kari L. Franson, & Andrew Leber. (1991). Kinetics of uptake and effects of topical indomethacin application on protein concentration in the aqueous humor of dogs. American Journal of Veterinary Research. 52(7). 1159–1163. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Daniella Carretta Breakdown of academic impact, for papers by Pablo Alarcón Breakdown of academic impact, for papers by Mariana Haydee García-Hernández Breakdown of academic impact, for papers by Gabriel Fung Breakdown of academic impact, for papers by Deepa Machiah Breakdown of academic impact, for papers by Katarzyna Kołodziejska Breakdown of academic impact, for papers by Eric M. Walton Breakdown of academic impact, for papers by Paul Cheung Breakdown of academic impact, for papers by Ann-Katrin Hopp
Rankless by CCL
2026